STOCK COMMENTS/EPS CHANGESBiogen Idec ( BIIB) numbers were boosted at Bank of America/Merrill Lynch. Shares are now seen reaching $177. Estimates were also increased, given higher expect multiple sclerosis sales. Neutral rating. Express Scripts ( ESRX) numbers were increased at Citigroup. Estimates were boosted through 2014. Company is keeping a tight lid on costs, Citi said. Buy rating and new $64 price target. JC Penney ( JCP) numbers were reduced at Citi. Shares are now seen reaching $22. Estimates were also cut, as lower sales continue to cut into margins, Citi said. Buy rating. Range Resources ( RRC) numbers were raised at BMO Capital. Shares are now seen reaching $84. Estimates were also increased, as the company is realizing higher production growth, BMO Capital said. Outperform rating. Sunpower ( SPWR) estimates, price target were upped at Citigroup. Company should see growth through Japan and joint ventures, Citi said. Buy rating and new $16 price target. Verisk Analytics ( VRSK) numbers were increased at Credit Suisse. Estimates were raised through 2014. Revenue growth continues to accelerate, Credit Suisse said. Outperform rating and new $63 price target. >To submit a news tip, email: email@example.com.
Twitter and become a fan on Facebook.